EMCURE PHARMACEUTICALS
Back to Cashflow Statement
|
EMCURE PHARMACEUTICALS Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹852 Cr | ₹1,097 Cr | ₹747 Cr | ₹768 Cr | ₹704 Cr |
What is the latest Cash Flow from Operating Activities ratio of EMCURE PHARMACEUTICALS ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹852 Cr |
| Mar2024 | ₹1,097 Cr |
| Mar2023 | ₹747 Cr |
| Mar2022 | ₹768 Cr |
| Mar2021 | ₹704 Cr |
How is Cash Flow from Operating Activities of EMCURE PHARMACEUTICALS Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹852 Cr | -22.38 | |
| Mar2024 | ₹1,097 Cr | 46.92 | |
| Mar2023 | ₹747 Cr | -2.78 | |
| Mar2022 | ₹768 Cr | 9.05 | |
| Mar2021 | ₹704 Cr | - | |
Compare Cash Flow from Operating Activities of peers of EMCURE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EMCURE PHARMACEUTICALS | ₹27,899.6 Cr | -2.5% | 2.5% | 57.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹421,407.0 Cr | -2.2% | 2.5% | 1.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,596.0 Cr | -1.2% | -4.5% | 5.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹142,619.0 Cr | -2.1% | -0.2% | 36.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,544.0 Cr | -2.4% | -2.1% | 11.5% | Stock Analytics | |
| CIPLA | ₹98,767.6 Cr | -4.6% | -8% | -16.8% | Stock Analytics | |
EMCURE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EMCURE PHARMACEUTICALS | -2.5% |
2.5% |
57.6% |
| SENSEX | -3.7% |
-13.2% |
-2% |
You may also like the below Video Courses